Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS

Ingrid Walter(University of Veterinary Medicine Vienna), Ralf Steinborn(University of Veterinary Medicine Vienna)

Oncology Reports

December 30, 2013

10.3892/or.2013.2954

Cited by 14

Related Papers

No related papers found

Powered by citation graph analysis